Regulations.gov document
Determination That AZO GANTANOL (Phenazopyridine Hydrochloride, Sulfamethoxazole) Tablet…
Notice · FDA-2006-P-0136 · posted Jun 12, 2014
Key facts
| Document ID | FDA-2006-P-0136-0007 |
|---|---|
| Title | Determination That AZO GANTANOL (Phenazopyridine Hydrochloride, Sulfamethoxazole) Tablet, 100 Milligrams/500 Milligrams, and AZO GANTRISIN (Phenazopyridine Hydrochloride, Sulfisoxazole) Tablet, 50 Milligrams/500 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | General Notice |
| Agency | FDA |
| Docket | FDA-2006-P-0136 |
| Posted | Jun 12, 2014 |
| Federal Register citation | 79 FR 33757 |
| FR document number | 2014-13757 |
| Comment period opens | Jun 12, 2014 |
| Effective date | Jun 12, 2014 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: